Company news
PTC Therapeutics, Inc. news in 2020
PTC Therapeutics, Inc.'s news releases, calls and decks from 2020, newest first.
PTC Announces Translarna™ Approval in Russia for the Treatment of Duchenne Muscular Dystrophy
December 3, 2020
PTC Therapeutics Announces Initiation of Global Phase 3 Clinical Trial to Evaluate Vatiquinone in Friedreich Ataxia
November 29, 2020
PTC Therapeutics Announces Key Regulatory Designations for PTC596 to Advance Treatment of Two Rare Oncology Indications
November 17, 2020
PTC Therapeutics Announces that PTC518 Has Entered into a Phase 1 Clinical Trial for the Huntington's Disease Program
November 16, 2020
PTC Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Corporate Update
October 28, 2020
PTC Therapeutics Announces Initiation of a Registration-Directed Clinical Trial to Evaluate Vatiquinone in Mitochondrial Epilepsy
October 25, 2020
PTC Therapeutics and AADC Family Network Announce First-Ever AADC Deficiency Awareness Day in Massachusetts
October 21, 2020
PTC Therapeutics Launches PTC PINPOINT - A Genetic Testing Program for Individuals Suspected of Having Neurotransmitter Disorders
September 8, 2020
PTC Therapeutics' 2020 STRIVE Awards for Duchenne Muscular Dystrophy Recognize Four Patient Advocacy Organizations
September 7, 2020
PTC Therapeutics Announces First Commercial Milestone Payment Following U.S. FDA Approval of Evrysdi™ (risdiplam)
August 25, 2020
PTC Announces the Acceptance of the European Marketing Authorization Application for Evrysdi™ (risdiplam) for the Treatment of Spinal Muscular Atrophy
August 16, 2020
PTC Therapeutics Announces FDA Approval of Evrysdi™ (risdiplam) for the Treatment of Spinal Muscular Atrophy in Adults and Children 2 months and older
August 6, 2020
PTC Therapeutics Reports Second Quarter 2020 Financial Results and Provides a Corporate Update
August 4, 2020
PTC Therapeutics Announces Agreement to Monetize a Portion of the Risdiplam Royalty Stream for $650 Million
July 19, 2020
PTC Therapeutics Announces First Patient Dosed in Phase 1 Trial for PTC857
July 7, 2020
PTC Therapeutics Announces CHMP Recommendation of Translarna™ (ataluren) Label Update for Non-Ambulatory Patients with Duchenne Muscular Dystrophy
June 28, 2020
PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19
June 16, 2020
PTC Therapeutics Announces 2-year Data from Part 1 of SUNFISH and New Data from JEWELFISH Trials for Risdiplam in Patients with Spinal Muscular Atrophy
June 11, 2020
PTC Therapeutics Launches New "Talent Pipeline Program" to Help Students who Graduated During the 2020 COVID-19 Pandemic
June 9, 2020
PTC Therapeutics Successfully Completes Acquisition of Censa Pharmaceuticals
May 31, 2020
PTC Therapeutics, Inc. to Hold Virtual 2020 Annual Meeting of Stockholders
May 26, 2020
PTC Therapeutics to Acquire Censa Pharmaceuticals
May 5, 2020
PTC Therapeutics Reports First Quarter 2020 Financial Results and Provides a Corporate Update
April 29, 2020
Confirmatory Part 2 of FIREFISH Demonstrates Survival and Motor Milestones Not Seen in Natural History in Infants with Type 1 Spinal Muscular Atrophy
April 27, 2020
PTC Therapeutics Announces New Leadership Appointments
April 16, 2020
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2020 Financial Results
April 15, 2020
PTC Announces Regulatory Update on Risdiplam for Spinal Muscular Atrophy (SMA)
April 6, 2020
PTC Therapeutics Announces Management Change
March 15, 2020
PTC Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides a Corporate Update
March 1, 2020
PTC Therapeutics Launches Sixth Annual STRIVE Awards Program for Advocacy Organizations in Duchenne Muscular Dystrophy
February 17, 2020
PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2019 Financial Results
February 16, 2020
PTC Therapeutics Announces First Publication of Real-World Data Showing Translarnaä (ataluren) Significantly Preserves Ability to Walk for Longer in Children with Duchenne Muscular Dystrophy
February 2, 2020
Decks in 2020
- 2020 J.P. Morgan Healthcare Conference
Conference · 37 slides · Jan 17, 2020